Growth Metrics

Solid Biosciences (SLDB) Free Cash Flow (2017 - 2026)

Quarterly results put Free Cash Flow at -$47.3 million for Q1 2026, down 48.0% from a year ago — trailing twelve months through Mar 2026 was -$171.7 million (down 61.03% YoY), and the annual figure for FY2025 was -$156.3 million, down 56.32%.

Solid Biosciences has reported Free Cash Flow over the past 10 years, most recently at -$47.3 million for Q1 2026.

  • Free Cash Flow reached -$47.3 million in Q1 2026 per SLDB's latest filing, up from -$53.3 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$16.2 million in Q2 2022 and bottomed at -$53.3 million in Q4 2025.
  • Median Free Cash Flow over the past 5 years was -$27.5 million (2022), compared with a mean of -$29.3 million.
  • The largest annual shift saw Free Cash Flow surged 35.79% in 2023 before it plummeted 79.92% in 2025.
  • Over 5 years, Free Cash Flow stood at -$34.8 million in 2022, then surged by 35.79% to -$22.3 million in 2023, then tumbled by 32.55% to -$29.6 million in 2024, then tumbled by 79.92% to -$53.3 million in 2025, then rose by 11.29% to -$47.3 million in 2026.
  • Business Quant data shows Free Cash Flow for SLDB at -$47.3 million in Q1 2026, -$53.3 million in Q4 2025, and -$33.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -1.67 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.29 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 848.30 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 48.67 Mn
10 Solid Biosciences 713.77 Mn 333.09 Mn - -47.26 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -47.26 Mn
Mar 31, 2026 -47.26 Mn
Dec 31, 2025 -53.27 Mn
Dec 31, 2025 -53.27 Mn
Sep 30, 2025 -33.30 Mn
Sep 30, 2025 -33.30 Mn
Jun 30, 2025 -37.84 Mn
Jun 30, 2025 -37.84 Mn
Mar 31, 2025 -31.93 Mn
Mar 31, 2025 -31.93 Mn
Dec 31, 2024 -29.61 Mn
Dec 31, 2024 -29.61 Mn
Sep 30, 2024 -23.72 Mn
Sep 30, 2024 -23.72 Mn
Jun 30, 2024 -21.34 Mn
Jun 30, 2024 -21.34 Mn
Mar 31, 2024 -25.34 Mn
Mar 31, 2024 -25.34 Mn
Dec 31, 2023 -22.34 Mn
Dec 31, 2023 -22.34 Mn
Sep 30, 2023 -17.76 Mn
Sep 30, 2023 -17.76 Mn
Jun 30, 2023 -27.10 Mn
Jun 30, 2023 -27.10 Mn
Mar 31, 2023 -28.50 Mn
Mar 31, 2023 -28.50 Mn
Dec 31, 2022 -34.79 Mn
Dec 31, 2022 -34.79 Mn
Sep 30, 2022 -20.05 Mn
Sep 30, 2022 -20.05 Mn
Jun 30, 2022 -16.21 Mn
Jun 30, 2022 -16.21 Mn
Mar 31, 2022 -27.45 Mn
Mar 31, 2022 -27.45 Mn
Dec 31, 2021 -20.36 Mn
Dec 31, 2021 -20.36 Mn
Sep 30, 2021 -19.00 Mn
Sep 30, 2021 -19.00 Mn
Jun 30, 2021 -17.11 Mn
Jun 30, 2021 -17.11 Mn
Mar 31, 2021 -21.40 Mn
Mar 31, 2021 -21.40 Mn
Dec 31, 2020 1.25 Mn
Dec 31, 2020 1.25 Mn
Sep 30, 2020 -15.64 Mn
Sep 30, 2020 -15.64 Mn
Jun 30, 2020 -13.77 Mn
Jun 30, 2020 -13.77 Mn
Mar 31, 2020 -29.33 Mn
Mar 31, 2020 -29.33 Mn
Dec 31, 2019 -21.89 Mn
Dec 31, 2019 -21.89 Mn
Sep 30, 2019 -19.89 Mn
Sep 30, 2019 -19.89 Mn
Jun 30, 2019 -27.44 Mn
Jun 30, 2019 -27.44 Mn
Mar 31, 2019 -27.88 Mn
Mar 31, 2019 -27.88 Mn
Dec 31, 2018 -21.84 Mn
Dec 31, 2018 -21.84 Mn
Sep 30, 2018 -11.59 Mn
Sep 30, 2018 -11.59 Mn
Jun 30, 2018 -19.55 Mn
Jun 30, 2018 -19.55 Mn
Mar 31, 2018 -18.17 Mn
Mar 31, 2018 -18.17 Mn
Dec 31, 2017 -12.30 Mn
Dec 31, 2017 -12.30 Mn
Sep 30, 2017 -11.07 Mn
Sep 30, 2017 -11.07 Mn
Jun 30, 2017 -9.91 Mn
Jun 30, 2017 -9.91 Mn
Mar 31, 2017 -10.21 Mn
Mar 31, 2017 -10.21 Mn